Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for poly adp- ribose) polymerases
Most Correlated Studies
- Lymphoblastoid B cells treated with olaparib to inhibit poly(ADP-ribose) polymerase (PARP)
- Cervical cancer HeLa cells with PARP-1 siRNA knockdown
- Ovarian cancer cells resistant to Olaparib or shRNA-mediated CEBPB knockdown
- Acute myeloid leukemia C1498 cells treated with PARP1 inhibitor PJ-34
- Burkitt lymphoma DG-75 cells expressing EBV LMP1 and treated with olaparib
Most Relevant Literature
- PARP inhibitors--theoretical basis and clinical application].
- Poly(ADP-ribose)polymerases are involved in microhomology mediated back-up non-homologous end joinin…
- Differential role of poly(ADP-ribose) polymerase in D. discoideum growth and development.
- Purification of recombinant poly(ADP-ribose) polymerases.
- Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase …
Most Relevant Clinical Trials
- A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (P…
- Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) …
- Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) E…
- Olaparib for PAH: a Multicenter Clinical Trial
- Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer
